A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy

Jonathan E. Dowell, David H. Johnson, John S. Rogers, Yu Shyr, Nancy Mccullough, Peggy Krozely, Russell F. DeVore

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences